Tokyo, Japan and Cambridge and London, UK, 17 November 2025 - Nxera Pharma Co., Ltd. ('Nxera” or 'the Company”; TSE 4565) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback